A UW Hospital physician completed a nationwide study that will help develop a treatment likely to change the way certain types of vision loss are treated, UW Health officials announced Monday.
According to a release, Dr. Michael Ip, UW-Madison School of Medicine professor of ophthalmology and visual sciences, chaired the trial, which focused on studying the blood vessels in the back of the eye.
Ip said the trial revealed that the injection of certain steroids into the large blood vessels of the eye could decrease vision loss caused by a condition called Central Vein Retinal Occlusion (CRVO).
Ip said the study's results have made way for the first long term effective treatment for this condition, which is the second leading factor causing vision loss among patients.
""We're very happy,"" he said. ""These are definitely some welcomed results.""
According to the release, Ip also co-chaired a study that found these steroid injections are equally as successful as laser eye surgeries, which typically treat vision loss due to the blockage of the smaller vessels.